On one hand, constitutively expressed NF-κB has been demonstrated to lead to resistance to cell death by different inducers of apoptosis and increased NF-κB activity has recently been correlated with progression of different cancers, especially breast cancer, melanoma, and juvenile myelomonocytic leukemia [43]. This evidence concerns the gene NFKB1 and cancer.